Login to Your Account


SAN FRANCISCO – While the medical device industry remains true to its roots, seeking to improve the duration and quality of lives across many conditions, the $371 billion industry is increasingly seeking ways to push beyond incremental innovation.

The regulatory law firm of Epstein Becker Green has petitioned the FDA to set a limit to the number of days the agency can take to review petitions regarding combo product designations.

While Republicans and Democrats in the U.S. House are at odds over proposed changes to the ACA, their colleagues in the Senate are working together to rein in drug prices.

More U.S. Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: